FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046579689> ?p ?o ?g. }

• W2046579689 endingPage "2438" @default.
• W2046579689 startingPage "2427" @default.
• W2046579689 abstract "Despite the prevalent worldwide abuse of stimulants, such as amphetamines and cocaine, no medications are currently approved for treating this serious public health problem. Both preclinical and clinical studies suggest that the opioid antagonist naltrexone (NTX) is effective in reducing the abuse liability of amphetamine, raising the question of whether similar positive findings would be obtained for cocaine. The purpose of this study was to evaluate the ability of oral NTX to alter the cardiovascular and subjective effects of D-amphetamine (D-AMPH) and cocaine (COC). Non-treatment-seeking COC users (N=12) completed this 3-week inpatient, randomized, crossover study. Participants received 0, 12.5, or 50 mg oral NTX 60 min before active or placebo stimulant administration during 10 separate laboratory sessions. Oral AMPH (0, 10, and 20 mg; or all placebo) was administered in ascending order within a laboratory session using a 60-min interdose interval. Smoked COC (0, 12.5, 25, and 50 mg; or all placebo) was administered in ascending order within a laboratory session using a 14-min interdose interval. Active COC and AMPH produced dose-related increases in cardiovascular function that were of comparable magnitude. In contrast, COC, but not AMPH, produced dose-related increases in several subjective measures of positive drug effect (eg, high, liking, and willingness to pay for the drug). NTX did not alter the cardiovascular effects of AMPH or COC. NTX also did not alter positive subjective ratings after COC administration, but it did significantly reduce ratings of craving for COC and tobacco during COC sessions. These results show that (1) oral AMPH produces minimal abuse-related subjective responses in COC smokers, and (2) NTX reduces craving for COC and tobacco during COC sessions. Future studies should continue to evaluate NTX as a potential anti-craving medication for COC dependence." @default.
• W2046579689 created "2016-06-24" @default.
• W2046579689 creator A5001055407 @default.
• W2046579689 creator A5001865213 @default.
• W2046579689 creator A5002562374 @default.
• W2046579689 creator A5002859937 @default.
• W2046579689 creator A5005141654 @default.
• W2046579689 creator A5016148375 @default.
• W2046579689 creator A5023998451 @default.
• W2046579689 creator A5024482763 @default.
• W2046579689 creator A5025809329 @default.
• W2046579689 creator A5031168930 @default.
• W2046579689 creator A5051088885 @default.
• W2046579689 creator A5067718462 @default.
• W2046579689 creator A5068068755 @default.
• W2046579689 creator A5082255545 @default.
• W2046579689 creator A5082662287 @default.
• W2046579689 creator A5087602950 @default.
• W2046579689 creator A5088269697 @default.
• W2046579689 date "2013-06-05" @default.
• W2046579689 modified "2023-10-10" @default.
• W2046579689 title "Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers" @default.
• W2046579689 cites W1582488684 @default.
• W2046579689 cites W1964510410 @default.
• W2046579689 cites W1965521085 @default.
• W2046579689 cites W1982283217 @default.
• W2046579689 cites W1982873206 @default.
• W2046579689 cites W1986084600 @default.
• W2046579689 cites W1990391721 @default.
• W2046579689 cites W2010129571 @default.
• W2046579689 cites W2016081949 @default.
• W2046579689 cites W2026839570 @default.
• W2046579689 cites W2028184368 @default.
• W2046579689 cites W2028857574 @default.
• W2046579689 cites W2030038312 @default.
• W2046579689 cites W2037459329 @default.
• W2046579689 cites W2040116927 @default.
• W2046579689 cites W2040197429 @default.
• W2046579689 cites W2053274920 @default.
• W2046579689 cites W2059678901 @default.
• W2046579689 cites W2065763048 @default.
• W2046579689 cites W2072489212 @default.
• W2046579689 cites W2074429989 @default.
• W2046579689 cites W2076116464 @default.
• W2046579689 cites W2083438273 @default.
• W2046579689 cites W2089488334 @default.
• W2046579689 cites W2090627492 @default.
• W2046579689 cites W2104538950 @default.
• W2046579689 cites W2116763568 @default.
• W2046579689 cites W2122284725 @default.
• W2046579689 cites W2145470904 @default.
• W2046579689 cites W2146087027 @default.
• W2046579689 cites W2146955358 @default.
• W2046579689 cites W2157564334 @default.
• W2046579689 cites W2160878378 @default.
• W2046579689 cites W2168620692 @default.
• W2046579689 cites W2313458738 @default.
• W2046579689 cites W2321872756 @default.
• W2046579689 cites W4235076757 @default.
• W2046579689 doi "https://doi.org/10.1038/npp.2013.143" @default.
• W2046579689 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3799062" @default.
• W2046579689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23736314" @default.
• W2046579689 hasPublicationYear "2013" @default.
• W2046579689 type Work @default.
• W2046579689 sameAs 2046579689 @default.
• W2046579689 citedByCount "47" @default.
• W2046579689 countsByYear W20465796892014 @default.
• W2046579689 countsByYear W20465796892015 @default.
• W2046579689 countsByYear W20465796892016 @default.
• W2046579689 countsByYear W20465796892017 @default.
• W2046579689 countsByYear W20465796892018 @default.
• W2046579689 countsByYear W20465796892020 @default.
• W2046579689 countsByYear W20465796892021 @default.
• W2046579689 countsByYear W20465796892022 @default.
• W2046579689 countsByYear W20465796892023 @default.
• W2046579689 crossrefType "journal-article" @default.
• W2046579689 hasAuthorship W2046579689A5001055407 @default.
• W2046579689 hasAuthorship W2046579689A5001865213 @default.
• W2046579689 hasAuthorship W2046579689A5002562374 @default.
• W2046579689 hasAuthorship W2046579689A5002859937 @default.
• W2046579689 hasAuthorship W2046579689A5005141654 @default.
• W2046579689 hasAuthorship W2046579689A5016148375 @default.
• W2046579689 hasAuthorship W2046579689A5023998451 @default.
• W2046579689 hasAuthorship W2046579689A5024482763 @default.
• W2046579689 hasAuthorship W2046579689A5025809329 @default.
• W2046579689 hasAuthorship W2046579689A5031168930 @default.
• W2046579689 hasAuthorship W2046579689A5051088885 @default.
• W2046579689 hasAuthorship W2046579689A5067718462 @default.
• W2046579689 hasAuthorship W2046579689A5068068755 @default.
• W2046579689 hasAuthorship W2046579689A5082255545 @default.
• W2046579689 hasAuthorship W2046579689A5082662287 @default.
• W2046579689 hasAuthorship W2046579689A5087602950 @default.
• W2046579689 hasAuthorship W2046579689A5088269697 @default.
• W2046579689 hasBestOaLocation W20465796891 @default.
• W2046579689 hasConcept C118552586 @default.
• W2046579689 hasConcept C126322002 @default.
• W2046579689 hasConcept C142724271 @default.
• W2046579689 hasConcept C170493617 @default.

• next